- Home
- INKT vs GSIW Comparison
INKT vs GSIW Comparison
Compare INKT & GSIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- GSIW
- Stock Information
- Founded
- INKT 2017
- GSIW 2016
- Country
- INKT United States
- GSIW Hong Kong
- Employees
- INKT N/A
- GSIW N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- GSIW
- Sector
- INKT Health Care
- GSIW
- Exchange
- INKT Nasdaq
- GSIW Nasdaq
- Market Cap
- INKT 28.8M
- GSIW 27.2M
- IPO Year
- INKT 2021
- GSIW 2023
- Fundamental
- Price
- INKT $25.60
- GSIW $1.63
- Analyst Decision
- INKT Hold
- GSIW
- Analyst Count
- INKT 3
- GSIW 0
- Target Price
- INKT $37.50
- GSIW N/A
- AVG Volume (30 Days)
- INKT 2.7M
- GSIW 2.6M
- Earning Date
- INKT 08-12-2025
- GSIW 01-01-0001
- Dividend Yield
- INKT N/A
- GSIW N/A
- EPS Growth
- INKT N/A
- GSIW N/A
- EPS
- INKT N/A
- GSIW N/A
- Revenue
- INKT N/A
- GSIW $1,313,795.00
- Revenue This Year
- INKT N/A
- GSIW N/A
- Revenue Next Year
- INKT N/A
- GSIW N/A
- P/E Ratio
- INKT N/A
- GSIW N/A
- Revenue Growth
- INKT N/A
- GSIW N/A
- 52 Week Low
- INKT $4.56
- GSIW $0.35
- 52 Week High
- INKT $76.00
- GSIW $12.30
- Technical
- Relative Strength Index (RSI)
- INKT 58.01
- GSIW 72.13
- Support Level
- INKT $6.80
- GSIW $1.26
- Resistance Level
- INKT $76.00
- GSIW $1.66
- Average True Range (ATR)
- INKT 6.24
- GSIW 0.14
- MACD
- INKT 2.84
- GSIW -0.02
- Stochastic Oscillator
- INKT 29.68
- GSIW 92.25
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About GSIW Garden Stage Limited
Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: a) I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong, and b) I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.